Search Results - Sarah Gooding

  • Showing 1 - 7 results of 7
Refine Results
  1. 1

    Resistance to immunomodulatory drugs in multiple myeloma: the cereblon pathway and beyond by Phaik Ju Teoh, Mun Yee Koh, Constantine Mitsiades, Sarah Gooding, Wee Joo Chng

    Published in Haematologica (2024-11-01)
    Get full text
    Article


  2. 2

    Precision medicine for liver tumours with quantitative MRI and whole genome sequencing (Precision1 trial): study protocol for observational cohort study by Matt Kelly, Rajarshi Banerjee, Myrddin Rees, Fenella K Welsh, John J Connell, Sarah Gooding

    Published in BMJ Open (2022-04-01)
    Get full text
    Article


  3. 3

    P1362: DEVELOPMENT OF A NOVEL ONCOLYTIC VIRUS -THEO-310 - SPECIALISED FOR TARGETING THE BONE MARROW TUMOUR MICROENVIRONMENT OF MULTIPLE MYELOMA PATIENTS by Rebecca Bamford, Shayda Maleki-Toyserkani, Will Taverner, Josh Freedman, Matt Hayman, Manoj Saini, Sarah Gooding, Karthik Ramasamy, Kerry Fisher, Margaret Duffy

    Published in HemaSphere (2023-08-01)
    Get full text
    Article


  4. 4

    Validation of clinical‐grade whole genome sequencing reproduces cytogenetic analysis and identifies mutational landscape in newly‐diagnosed multiple myeloma patients: A pilot study... by Oliver C. Lomas, Sarah Gooding, Maite Cabes, Helene Dreau, Edward Wilson, Paolo Polzella, Genomics England Research Consortium, Karthik Ramasamy, Angela D. Hamblin

    Published in eJHaem (2021-11-01)
    Get full text
    Article


  5. 5

    Risk adapted therapy for newly diagnosed multiple myeloma delivered through local cytogenetic laboratories in a National Clinical Trial: UKMRA RADAR study by Dipal Mehta, Robert Cicero, Laura Chiecchio, Samir Asher, Martin Kaiser, Sarah Gooding, Kara‐Louise Royle, Catherine Olivier, Doina Levinte, Charlotte Kennaway, Karthik Ramasamy, Kwee Yong, Matthew Jenner

    Published in eJHaem (2025-06-01)
    Get full text
    Article


  6. 6

    Longitudinal dynamics and clinically available predictors of poor response to COVID-19 vaccination in multiple myeloma by Gaurav Agarwal, Sally Moore, Ross Sadler, Sherin Varghese, Alison Turner, Lucia Y Chen, Jemma Larham, Nathanael Gray, Oluremi Carty, Joe Barrett, Constantinos Koshiaris, Jaimal Kothari, Stella Bowcock, Udo Oppermann, Vicky Gamble, Gordon Cook, Chara Kyriakou, Mark Drayson, Supratik Basu, Sarah McDonald, Shelagh McKinley, Sarah Gooding, Muhammad K Javaid, Karthik Ramasamy

    Published in Haematologica (2024-01-01)
    Get full text
    Article


  7. 7

    Prolyl-tRNA synthetase as a novel therapeutic target in multiple myeloma by Keiji Kurata, Anna-James Bott, Mark A. Tye, Leona Yamamoto, Mehmet K. Samur, Yu-Tzu Tai, James Dunford, Catrine Johansson, Filiz Senbabaoglu, Martin Philpott, Charlotte Palmer, Karthik Ramasamy, Sarah Gooding, Mihaela Smilova, Giorgia Gaeta, Manman Guo, John C. Christianson, N. Connor Payne, Kritika Singh, Kubra Karagoz, Matthew E. Stokes, Maria Ortiz, Patrick Hagner, Anjan Thakurta, Adam Cribbs, Ralph Mazitschek, Teru Hideshima, Kenneth C. Anderson, Udo Oppermann

    Published in Blood Cancer Journal (2023-01-01)
    Get full text
    Article


Search Tools: